Product NDC: | 0713-0632 |
Proprietary Name: | Fluticasone Propionate |
Non Proprietary Name: | Fluticasone Propionate |
Active Ingredient(s): | .05 mg/g & nbsp; Fluticasone Propionate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0713-0632 |
Labeler Name: | GW Laboratories, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077168 |
Marketing Category: | ANDA |
Start Marketing Date: | 20060531 |
Package NDC: | 0713-0632-31 |
Package Description: | 30 g in 1 TUBE (0713-0632-31) |
NDC Code | 0713-0632-31 |
Proprietary Name | Fluticasone Propionate |
Package Description | 30 g in 1 TUBE (0713-0632-31) |
Product NDC | 0713-0632 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fluticasone Propionate |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20060531 |
Marketing Category Name | ANDA |
Labeler Name | GW Laboratories, Inc |
Substance Name | FLUTICASONE PROPIONATE |
Strength Number | .05 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |